What's in Timber Pharmaceuticals Inc.'s pipeline?

Timber Pharmaceuticals Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Timber Pharmaceuticals Inc.'s portfolio?

Top competitors by shared drug class: Moberg Pharma AB.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/timber-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Timber Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Timber Pharmaceuticals Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
TMB-001	TMB-001	phase 3	Topical antifungal		Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Moberg Pharma AB · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Timber Pharmaceuticals Inc.:

Cite this brief

Drug Landscape (2026). Timber Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/timber-pharmaceuticals-inc. Accessed 2026-06-10.